NCT06943274 SWOC Activities on Balance, Gait and Endurance in Children With Autism Spectrum Disorder
| NCT ID | NCT06943274 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Riphah International University |
| Condition | Autism Spectrum Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2025-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2025-04-15 with a primary completion date of 2025-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Autism Spectrum Disorder (ASD) is a developmental disorder characterized by challenges in social communication, social interaction, repetitive behaviors, and restrictive interests. Affecting 0.2-2% of children, ASD often includes motor growth retardation, which worsens over time. The disorder is more commonly diagnosed in boys, and its cause is believed to be genetic, with environmental stimuli potentially activating certain genes. This study aims to explore the effects of Standardized Walking Obstacle Course (SWOC) activities on balance, gait, and endurance in children with ASD, seeking to discover novel treatment techniques that could enhance clinical practices and improve motor skills in these children. This randomized controlled trial will be conducted over 10 months, with data collected from the Lahore Autism Center and PSRD hospital in Lahore, Punjab. The sample will include 44 children with confirmed ASD, aged 8 to 12 years, divided into two groups: one undergoing SWOC activities and the other receiving conventional physiotherapy. Interventions will occur 4 days a week for 30-40 minutes each day. Pre- and post-treatment measurements will be taken using the Pediatric Balance Scale (PBS), the 6-Minute Walk Test (6MWT), and Functional Gait Assessment (FGA). Data will be analyzed using SPSS version 24, with statistical significance set at P = 0.05.
Eligibility Criteria
Inclusion Criteria: * Children with confirmed diagnosis of ASD. * Age of patients 8 to 12 year. * Both male and female. * Fall less than 15 times in 30 seconds in Flamingo balance scale test. Exclusion Criteria: * Severe physical impairment. * Severe intellectual impairment. * Comorbid conditions that could prevent participation.
Contact & Investigator
Kainat Subtain, MS-PPT
PRINCIPAL INVESTIGATOR
Riphah International University
Frequently Asked Questions
Who can join the NCT06943274 clinical trial?
This trial is open to participants of all sexes, aged 8 Years or older, up to 12 Years, studying Autism Spectrum Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06943274 currently recruiting?
Yes, NCT06943274 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.
Where is the NCT06943274 trial being conducted?
This trial is being conducted at Lahore, Pakistan.
Who is sponsoring the NCT06943274 clinical trial?
NCT06943274 is sponsored by Riphah International University. The principal investigator is Kainat Subtain, MS-PPT at Riphah International University. The trial plans to enroll 44 participants.